A multi-centre, open-label, Proof of Concept (PoC) study to evaluate the efficacy and tolerability of STI571 for the treatment of fibrosis in patients with systemic sclerosis A multi-centre, open-label, Proof of Concept (PoC) study to evaluate the efficacy and tolerability o ...
A multi-centre, open-label, Proof of Concept (PoC) study to evaluate the efficacy and tolerability of STI571 for the treatment of fibrosis in patients with systemic sclerosis A multi-centre, open-label, Proof of Concept (PoC) study to evaluate the efficacy and tolerability o ...